Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study

Marginal Structural Models and Causal Inference in Epidemiology

James M. Robins, Miguel A. Hernán, Babette Brumback · Epidemiology · 2000 · 5.5K citations

Public Health, Biostatistics, Causal Inference +14

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

Chris Parker, Sten Nilsson, Daniel Heinrich et al. · New England Journal of Medicine · 2013 · 3.3K citations

Medicine, Nuclear Medicine, Radiation Oncology +17

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

Nicholas D. James, Matthew R. Sydes, Noel W. Clarke et al. · The Lancet · 2015 · 2K citations · Full text

Medicine, Oncology, Urology +17

Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer

F. Saad, D. M. Gleason, R. Murray et al. · JNCI Journal of the National Cancer Institute · 2004 · 1.2K citations

Medicine, Pharmacology, Pharmacotherapy +14

Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan

Mark S. Soloway, Stephen W. Hardeman, David P. Hickey et al. · Cancer · 1988 · 638 citations

Medicine, Oncology, Radiology +17